Entegris (ENTG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Q4 2024 net sales reached $850 million, up 11% year-over-year excluding divestitures, with record sales in both Material Solutions and Advanced Purity Solutions divisions.
Full-year 2024 net sales were $3.24 billion, with adjusted net sales (excluding divestitures) up 4.6% and net income of $292.8 million.
Profitability was strong, with Q4 adjusted EBITDA margin at 29.2% and non-GAAP EPS of $0.84, both exceeding guidance.
Segment realignment now reports two segments: Materials Solutions (MS) and Advanced Purity Solutions (APS).
Growth was driven by advanced logic and AI-related semiconductor customers, while mainstream and memory segments remained weak.
Financial highlights
Q4 2024 gross margin was 45.6% (GAAP and non-GAAP), up from 42.4% a year ago; adjusted EBITDA margin was 29.2%.
Q4 2024 GAAP net income was $102.2 million; non-GAAP net income was $127.5 million.
Full-year 2024 adjusted EBITDA was $931.1 million, 28.7% of sales.
Q4 2024 non-GAAP EPS was $0.84, above guidance; GAAP EPS was $0.67.
Q4 2024 free cash flow was $68.6 million; full-year free cash flow was $316.1 million.
Outlook and guidance
Q1 2025 sales expected between $775 million and $805 million, up 7% year-over-year at midpoint (ex-divestitures); gross margin 45.5-46.5%.
Q1 2025 GAAP net income guidance: $58M–$68M; non-GAAP net income: $97M–$108M; non-GAAP EPS: $0.64–$0.71.
Q1 2025 adjusted EBITDA margin expected at 28.0% to 29.0%.
2025 sales expected at approximately $3.4 billion, up 6.5% pro forma, with market growth of 1-3% and outperformance of 4-5 points.
2025 CapEx expected at $325 million (10% of sales); free cash flow margin targeted to return to mid- to high-teens over several years.
Latest events from Entegris
- Annual meeting to vote on directors, compensation, auditor, and key shareholder rights changes.ENTG
Proxy filing23 Mar 2026 - Proxy covers leadership transition, governance reforms, and performance-based compensation changes.ENTG
Proxy filing23 Mar 2026 - Strategic growth, governance reforms, and enhanced ESG drive long-term value creation.ENTG
Proxy Filing6 Mar 2026 - Q4 2025 delivered strong sales and margins, with robust 2026 guidance and ongoing deleveraging.ENTG
Q4 202510 Feb 2026 - Q2 sales rose sequentially with strong margins; Q3 guidance and investments support further growth.ENTG
Q2 20242 Feb 2026 - Adjusted sales up 7% year-over-year; Q4 outlook signals margin strength and cost savings.ENTG
Q3 202417 Jan 2026 - Q2 2025 sales were $792.4M, with Q3 non-GAAP EPS guided at $0.68–$0.75.ENTG
Q2 202517 Dec 2025 - Strong 2024 growth, robust governance, and key votes on directors, pay, auditor, and voting rights.ENTG
Proxy Filing1 Dec 2025 - Q1 2025 net sales rose 5% adjusted, with margin gains and tariff risks impacting outlook.ENTG
Q1 202517 Nov 2025